The decision of Wuxi Zhanxin's parent fund to establish its first sub fund has been officially announced to the public
Today, the Wuxi Zhanxin Industry Special Fund of Funds plans to participate in the sub fund through the Jiangsu Province Strategic Emerging Industry Fund of Funds decision. The proposed equity sub funds are as follows:
Jiangsu Wuxi Jinyu Maogu Biomedical Fund: The total fund size is 1 billion yuan, registered in Jiangyin City, Wuxi, with a duration of 9 years. This fund focuses on high-quality projects in the upstream and downstream of the biopharmaceutical industry chain, adhering to a comprehensive strategic insight and layout consideration of the biopharmaceutical industry. It also provides comprehensive and in-depth support to outstanding technology-based enterprises that have emerged in other sub sectors.
According to the requirements of the selection announcement for the management institution of the industry sub fund of the Jiangsu Wuxi Biomedical Industry Special Fund of Funds (hereinafter referred to as the "Biomedical Industry Special Fund of Funds") of the Jiangsu Province Strategic Emerging Industry Fund of Funds, after the procedures of institutional application, preliminary review of materials, due diligence, expert evaluation, investment decision-making, etc., the first batch of proposed participating sub funds of the Biomedical Industry Special Fund of Funds for 2024 (see attachment for details) are now publicly announced. The public announcement period is from December 24, 2024 to December 30, 2024, with a public announcement period of 5 working days.
If any unit or individual has objections to the results of the public announcement, please raise them in writing during the public announcement period, and list the reasons for the objections and relevant supporting materials. If raised in the name of the unit, the official seal of the unit should be affixed to the objection materials; If submitted in the name of an individual, their real name, affiliation, contact address, and contact information must be clearly stated, and they must sign on the objection materials. To ensure objectivity, fairness, impartiality, and timeliness in handling objections, any anonymous or overdue objections will not be accepted.
Contact: Manager 0510-83692288
Contact email: wxzx@wuxicapital.com.cn
Address: Floor 25, Guolian Financial Building, No. 10, Financial 1st Street, the Taihu Lake New Town, the Taihu Lake Street, Binhu District, Wuxi City, Jiangsu Province
Wuxi Innovation Investment Group Co., Ltd
Attachment: List of Proposed Participating Sub Funds of Jiangsu Wuxi Biomedical Industry Special Fund of Funds
Fund Name: Jiangsu Wuxi Jinyu Maoguo Biomedical Venture Capital Partnership Enterprise (Limited Partnership) (tentative name)
Management Organization: Jinyu Maogu Investment Management Co., Ltd
Special note: This announcement is made in accordance with the "Announcement on the Selection of Management Institutions for the Industrial Sub Fund of Jiangsu Wuxi Biomedical Industry Special Fund of Funds (Limited Partnership) of Jiangsu Province Strategic Emerging Industry Fund of Funds", and does not represent any investment commitment made by the Biomedical Industry Special Fund of Funds. The investment obligation of the Biomedical Industry Special Fund of Funds shall be subject to the final signed partnership agreement/company articles of association and other valid investment documents.
